TC BioPharm (Holdings) plc Warrants
TCBPW
TCBPW was delisted on the 21st of March, 2025.
8 hedge funds and large institutions have $25.1K invested in TC BioPharm (Holdings) plc Warrants in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and closing their positions.
60% more funds holding
Funds holding: 5 → 8 (+3)
53% more capital invested
Capital invested by funds: $16.4K → $25.1K (+$8.73K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$43.2K |
| 2 |
VF
Virtu Financial
New York
|
+$697 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$316 |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$267 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$12 |
Top Sellers
TCBPW Hedge Fund Activity: Q4 2023 in Review
8 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q4 2023, worth a combined $25.1K — up 53% from $16.4K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new TCBPW positions and 0 closed out — a net gain of 3 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Armistice Capital, adding an estimated $43.2K.
- 8 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q4 2023, up from 5 in Q3 2023.
- Funds reported $25.1K of TC BioPharm (Holdings) plc Warrants stock for Q4 2023, up 53% quarter-over-quarter.
- 3 funds opened new TC BioPharm (Holdings) plc Warrants positions in Q4 2023 and 0 closed out, a net change of +3 holders.
- The largest TC BioPharm (Holdings) plc Warrants buyer in Q4 2023 was Armistice Capital, an estimated $43.2K added.
Based on aggregated 13F filings for Q4 2023.